Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cleveland Multiport Ventricular Catheter Set

K-Number: K161731 · 2017-03-27

ApplicantParker Hannifin Corp.
Decision Date2017-03-27
Product CodeHCA
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Cleveland Multiport Ventricular Catheter Set is a medical device manufactured by Parker Hannifin Corp.. It received FDA 510(k) clearance on 2017-03-27 under approval number K161731. The device is classified under product code HCA. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cleveland Multiport Ventricular Catheter Set?

Cleveland Multiport Ventricular Catheter Set is a medical device that received FDA 510(k) clearance on 2017-03-27. It is manufactured by Parker Hannifin Corp.. The 510(k) number is K161731.

When was Cleveland Multiport Ventricular Catheter Set approved by the FDA?

Cleveland Multiport Ventricular Catheter Set received FDA 510(k) clearance on 2017-03-27, under approval number K161731.

What company makes Cleveland Multiport Ventricular Catheter Set?

Cleveland Multiport Ventricular Catheter Set is manufactured by Parker Hannifin Corp..

What is the FDA product code for Cleveland Multiport Ventricular Catheter Set?

The FDA product code for Cleveland Multiport Ventricular Catheter Set is HCA.

Related Clinical Trials

NCT01254474 Evaluation of Depolarization and Repolarisation Activity During Cardiac Arrhythmia Using a Novel Monophasic Action Potential Catheter COMPLETED NCT03053141 RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) RECRUITING NCT06253858 Ultrasound (US) Guided External Ventricular Catheter Placement RECRUITING NCT05225935 Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia COMPLETED NCT05591118 Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy RECRUITING NCT07585968 Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT) NOT_YET_RECRUITING

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑